ZA200501759B - Lectin compositions and methods for modulating an immune response to an antigen - Google Patents

Lectin compositions and methods for modulating an immune response to an antigen

Info

Publication number
ZA200501759B
ZA200501759B ZA200501759A ZA200501759A ZA200501759B ZA 200501759 B ZA200501759 B ZA 200501759B ZA 200501759 A ZA200501759 A ZA 200501759A ZA 200501759 A ZA200501759 A ZA 200501759A ZA 200501759 B ZA200501759 B ZA 200501759B
Authority
ZA
South Africa
Prior art keywords
antigen
modulating
methods
immune response
lectin compositions
Prior art date
Application number
ZA200501759A
Other languages
English (en)
Inventor
Andrew H Segal
Young Elihu
Original Assignee
Genitrix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genitrix Llc filed Critical Genitrix Llc
Publication of ZA200501759B publication Critical patent/ZA200501759B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200501759A 2002-08-20 2003-08-20 Lectin compositions and methods for modulating an immune response to an antigen ZA200501759B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/224,661 US7629440B2 (en) 2002-08-20 2002-08-20 Lectin compositions and methods for modulating an immune response to an antigen

Publications (1)

Publication Number Publication Date
ZA200501759B true ZA200501759B (en) 2009-04-29

Family

ID=31886843

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200501759A ZA200501759B (en) 2002-08-20 2003-08-20 Lectin compositions and methods for modulating an immune response to an antigen

Country Status (3)

Country Link
US (1) US7629440B2 (zh)
CN (1) CN101119745B (zh)
ZA (1) ZA200501759B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040091503A1 (en) 2002-08-20 2004-05-13 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
KR20080042174A (ko) * 2005-10-07 2008-05-14 화이자 프로덕츠 인코포레이티드 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법
DK2257301T3 (da) 2008-03-03 2014-04-28 Univ Miami Immunterapi baseret på allogene cancerceller.
EP2405269B8 (en) * 2009-03-05 2016-10-12 National Institute of Advanced Industrial Science And Technology Method for detecting and distinguishing intrahepatic cholangiocarcinoma
DK2526119T3 (en) 2010-01-19 2018-07-30 Harvard College Manipulated opsonin for pathogen detection and treatment
WO2011100528A2 (en) * 2010-02-12 2011-08-18 Emory University Compositions and uses of lectins
CA2842321C (en) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2903637B1 (en) * 2012-10-02 2019-06-12 Memorial Sloan-Kettering Cancer Center Compositions and methods for immunotherapy
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
WO2014144147A2 (en) 2013-03-15 2014-09-18 HOLLISTER, Lisa Genetically modified plants that are insect-resistant and/or rot-resistant
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
AU2014329609B2 (en) * 2013-10-02 2019-09-12 Humabs Biomed Sa Neutralizing anti-influenza A antibodies and uses thereof
EP3083658B1 (en) 2013-12-18 2019-05-08 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
CN103739714B (zh) * 2013-12-30 2016-06-01 江苏众红生物工程创药研究院有限公司 TNFα与DC-SIGN的融合蛋白及其应用
CN106535922A (zh) * 2014-02-11 2017-03-22 北京艾棣维欣生物技术有限公司 免疫治疗组合物、治疗方法和诊断方法
EP3331549B1 (en) 2015-08-06 2020-12-23 President and Fellows of Harvard College Improved microbe-binding molecules and uses thereof
WO2017053327A1 (en) * 2015-09-24 2017-03-30 San Diego State University (Sdsu) Foundation , Dba San Diego State University Research Foundation Antibacterial and protective bacteriophage formulations and methods for making and using them
CN108753699B (zh) * 2018-06-19 2021-04-30 青岛农业大学 一种玉米赤霉烯酮对猪卵母细胞体外发育危害的挽救方法
CN113151596B (zh) * 2021-04-02 2023-08-08 中国医学科学院医学生物学研究所 一种四级生物安全实验室病毒化学淋浴消毒验证方法
CN113274484B (zh) * 2021-05-31 2022-04-08 中国食品药品检定研究院 小扁豆凝集素在制备预防和治疗冠状病毒引起的感染性疾病的药物中的应用
CN115981384B (zh) * 2023-02-07 2023-09-22 淮阴工学院 一种智能生物质orc蒸发压力控制设备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866136A (en) * 1986-08-01 1999-02-02 Commonwealth Scientific And Industrial Organisation Recombinant vaccine
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
US5891432A (en) 1997-07-29 1999-04-06 The Immune Response Corporation Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
IL139601A0 (en) * 1998-05-26 2002-02-10 Genitrix Llc Compositions and methods of modulating an immune response to an antigen

Also Published As

Publication number Publication date
US20040039156A1 (en) 2004-02-26
CN101119745B (zh) 2013-08-28
CN101119745A (zh) 2008-02-06
US7629440B2 (en) 2009-12-08

Similar Documents

Publication Publication Date Title
IL166998A (en) Preparation for the minor and methods for modulating the immune response to the antigen
ZA200501759B (en) Lectin compositions and methods for modulating an immune response to an antigen
ZA200706251B (en) Immune response modifier formulations and methods
EP1476456A4 (en) COMPOSITIONS AND METHOD FOR SUBROGEN-ANTIBODY MODULATION OF AN IMMUNE RESPONSE AND TRANSPORT
EP1572941A4 (en) NEW FLAVIVIRUS ANTIGENES
EP1578947A4 (en) ANTIBODIES AGAINST A2 PHOSPHOLIPASE AND USES
SI2206517T1 (sl) Imunopotencirni sestavki,ki obsegajo protitelesa proti PD-L1
EP1551447A4 (en) ANTI-ADDL ANTIBODIES AND USES THEREOF
IL172689A0 (en) Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE
IL175509A0 (en) Methods and agents for immune modulation
EP1617872A4 (en) METHODS AND COMPOSITIONS FOR ENHANCING AN IMMUNE RESPONSE
EP1689781A4 (en) ANTIBODIES TO CD44 GLYCOFORMS AND ITS APPLICATIONS
EP1483385A4 (en) COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE
GB0208081D0 (en) Skincare compositions and methods
EP1638513A4 (en) HIGHLY UNAVAILABLE CONNECTIONS AND METHOD OF USE THEREFOR
ZA200606331B (en) Method of inducing or modulating immune response
AU2002309486A8 (en) Methods and compositions for modulating the immune system of animals
EP1711527A4 (en) HLA-DR SPECIFIC ANTIBODIES, COMPOSITIONS AND METHODS
GB2422544B (en) Immune modulator
AU2003225710A8 (en) Composition and method for enhancing immune response
AU2003291151A8 (en) Compositions and methods for the reversible capture of biomolecules
AU2003237332A8 (en) Anti-relp fusion antibodies, compositions, methods and uses
GB0303645D0 (en) Method and compositions for boosting immune response
EP1583557A4 (en) VACCINE COMPOSITIONS AND METHODS
AU2002365894A8 (en) Antibodies to magmas and uses thereof